It is evident that biotech is a constantly evolving field, with new techniques and technologies emerging all the time. Some of these innovative techniques have the potential to completely change R&D in biotech startups and scaleups.

‍

CRISPR-Cas9

One of the most groundbreaking techniques is CRISPR-Cas9, a gene editing tool that allows biotech labs to make precise changes to the genome. This technology is based on a natural mechanism used by bacteria to defend against viruses and can be used to add, delete, or alter specific genes in any organism. CRISPR-Cas9 has been a real game changer making genetic engineering accessible to biotech startups and scaleups of all sizes. A number of  contract research organizations (CROs) also offer CRISPR-Cas9 services, allowing TechBio companies and virtual biotechs to gather data without building a complex wet lab.

‍

Synthetic Biology

Synthetic biology is the design and construction of new biological parts, devices, and systems that do not occur naturally. This interdisciplinary field combines techniques from engineering and computer science to create new organisms or modify existing ones for specific purposes, such as producing drugs or biofuels. Synthetic biology allows biotechs to create new tools, products, and services. Many biotech companies are emerging dedicated to creating the next generation of safe-for-the-people and safe-for-the-planet fibers.

‍

Organoids

Organoids, miniature three-dimensional models of organs grown from stem cells in the lab, are also making a significant impact in the biotech field. Startups can use organoids to study the development and function of organs and can to test drugs and other therapies.  TechBio companies and virtual biotechs can also outsource organoid-based screening to CROs.

‍

Metabolomics

Metabolomics, the study of metabolites produced by an organism as a result of metabolism, is another area of biotech that is rapidly evolving. This technique allows researchers to understand the impact of genetic or environmental changes on an organism's metabolism and can be used to identify new drug targets. This offers a new dimension paving the way towards innovative therapeutic approaches.

‍

Single-Cell Sequencing

Single-cell sequencing is another technique that has the potential to change the game of biotech research. This technique allows researchers to sequence the DNA or RNA of individual cells, rather than a population of cells, allowing biotech labs to study the genetic variation among cells and understand the underlying mechanisms of disease and response to treatment.

‍

Machine Learning

Machine learning, a subset of AI, is also making a significant impact in biotech. This technology allows systems to learn from data, identify patterns, and make decisions. Machine learning has many applications in areas such as drug discovery, drug development, and precision medicine, where it helps to make sense of huge datasets. 

‍

Microfluidics

Last but not the least, microfluidics, the study of the behavior of fluids at small scales, is being used to manipulate small volumes of fluids, such as cells, and perform a wide range of biological assays. One of the advantages of microfluidics is that it enables researchers to perform complex assays using very small amounts of reagents, which can be particularly useful when working with rare or expensive samples. Additionally, microfluidic devices can be designed to be highly customizable, allowing researchers to tailor their experiments to specific biological questions.

‍

Overall, microfluidics has become an important tool for researchers in the life sciences, enabling them to perform a wide range of experiments that would be difficult or impossible to achieve using traditional methods.

‍

These are just a few examples of the many innovative techniques and technologies currently being used in biotech startups and scaleups. The field is constantly evolving and new techniques are emerging all the time, making it an exciting and dynamic area of research and development.

‍

A Single, Unified Data and Lab Management Platform

Scispot’s configurable, user-friendly digital lab operating system is built so that biotech companies can manage their rapidly evolving and innovative workflows, data, operations, inventory, sales, investor relations, and more in one single platform. Scispot is the first ELN and LIMs replacement with graphical user interface (GUI) and command line interface so that companies can adapt the platform to perfectly fit their needs.

‍

Request a demo to see how Scispot can help you up your R&D game.

‍